Clinicopathologic parameters and immunohistochemical study of endometrial stromal sarcomas

Tzu I. Wu, Hung Hsueh Chou, Chi Ju Yeh, Swei Hsueh, Jung Erh Yang, Mei Shan Jao, Ting Chang Chang, Chun-Sen Hsu, Kwang Huei Lin, Chyong Huey Lai

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


We aimed to investigate the clinicopathologic features, immunohistochemical studies, and prognosis in patients with endometrial stromal sarcoma (ESS). Clinical information was reviewed retrospectively for cases of ESS (1985-2009). A histologic review and immunohistochemical staining for the estrogen receptor, progesterone receptor, c-Kit, CD-10, Ki-67, and m-TOR were performed. Sixty-one patients (median age, 44 y; range, 22-71) were eligible for analysis (1988 International Federation of Gynecology and Obstetrics Stage I, 43; Stage II, 2; Stage III, 11; Sage IV, 4; unstaged, 1). The median follow-up period for survivors was 73 mo. Of those, the patients who underwent an adnexectomy and a pelvic lymphadenectomy, 15% and 13%, respectively, revealed metastasis. There were 20 relapses/persistence, including 13 (65%) in the pelvis and abdomen and 7 (35%) in distant sites. Eight patients died from ESS at a median duration of 14.5 mo (range, 2-50 mo) after relapse. Five- and 10-yr cancer-specific survival (CSS) rates were 88% and 85%, respectively; and 5- and 10-yr progression-free survival rates were 69% and 57%, respectively. Stage, residual disease, and high proliferative index of Ki-67 were significant prognostic factors for both progression-free survival and CSS in a univariate analysis, in addition to mitotic index for CSS. Multivariate analysis selected only residual disease as an independent variable for progression-free survival and stage and residual disease for CSS. Our results support using clinical Stage I, no residual disease, low proliferative index of Ki-67, and estrogen receptor/progesterone receptor overexpression as potential biomarkers to select patients with ESS for fertility-preservation surgery (5 such patients were alive and free).

Original languageEnglish
Pages (from-to)482-492
Number of pages11
JournalInternational Journal of Gynecological Pathology
Issue number5
Publication statusPublished - Sept 2013


  • Endometrial stromal sarcoma
  • Immunohistochemistry
  • Prognostic factors
  • Survival

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Obstetrics and Gynaecology
  • Medicine(all)


Dive into the research topics of 'Clinicopathologic parameters and immunohistochemical study of endometrial stromal sarcomas'. Together they form a unique fingerprint.

Cite this